A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.

@article{Carette1989ADP,
  title={A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.},
  author={Simon Carette and Ana Maria Călin and James P. Mccafferty and Bruce A. Wallin},
  journal={Arthritis and rheumatism},
  year={1989},
  volume={32 2},
  pages={
          158-65
        }
}
Two hundred thirty-eight patients with psoriatic arthritis were entered into a 6-month, multicenter, double-blind trial comparing auranofin and placebo. Polyarthritis (greater than 5 tender joints) was present in 90% of the patients, and 94% were seronegative. Auranofin treatment was statistically superior to placebo treatment, according to physician's global assessment and functional scores. A trend in favor of auranofin treatment was seen for each of the other disease parameters studied… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Psoriatic Arthritis

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Diagnosis and management of psoriatic arthritis.

  • Indian journal of dermatology, venereology and leprology
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

Gabrielle H. Kingsley, Anna Kowalczyk, +10 authors David Scott
  • Rheumatology
  • 2012

Practical Prescribing Guidelines for Rheumatoid Arthritis

Hilary A Capell, Rajan Madhok, Iain B. McInnes
  • 2003